Replies to post #246 on Study of Signals (SoS)

[j.c.]

SNUS



Shares of Sonus Pharmaceuticals Inc (SNUS.O: Quote, Profile, Research) crashed more than 83 percent after the company said a late-stage trial of its lead experimental drug for metastatic breast cancer failed to meet its main goal.

[j.c.]